Propaganda or the cost of innovation? Challenging the high price of new drugs

BMJ. 2016 Mar 11:352:i1284. doi: 10.1136/bmj.i1284.

Authors

Narcyz Ghinea¹, Wendy Lipworth², Ian Kerridge²

Affiliations

¹ Centre for Values, Ethics and the Law in Medicine, University of Sydney, Sydney, New South Wales, Australia narcyz.ghinea@sydney.edu.au.
² Centre for Values, Ethics and the Law in Medicine, University of Sydney, Sydney, New South Wales, Australia.

PMID: 26968991
DOI: 10.1136/bmj.i1284

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Cost-Benefit Analysis
Diffusion of Innovation*
Drug Costs* / trends
Drug Design*
Drug Industry / economics*
Drug Industry / trends
Health Expenditures / statistics & numerical data*
Humans
National Health Programs / economics*
Pharmacopoeias as Topic
Propaganda